Updated Aug 13, 2019


MiracleFeet is solely focused on eliminating untreated clubfoot, a leading cause of physical disability worldwide. We provide organizational, technical, and financial support to clinics globally to treat children born with the condition.


Andrea Norris

Send Message

Stage 5: Scaling

MiracleFeet has transformed 39,000 children's lives through 189 clinics in 27 countries. In a 3rd party evaluation of our work in several countries, 94% of guardians report their child can walk without difficulty, proof our approach works and scales.

Registered as a Non-Profit.

Focus Areas:

Health Systems, Maternal Newborn and Child Health and Disability

Health Systems, Maternal Newborn and Child Health and DisabilitySEE LESS

Implemented In:

Bangladesh, Bolivia, Brazil and 24 MoreSEE ALL

Bangladesh, Bolivia, Brazil, Cambodia, Congo, Republic of the, Ecuador, Gambia, The, Guatemala, Guinea, India, Indonesia, Liberia, Madagascar, Mali, Myanmar, Nepal, Nicaragua, Nigeria, Paraguay, Philippines, Senegal, Somalia, Sri Lanka, Tanzania, Uganda, Vietnam and ZimbabweSEE LESS

Lives Impacted to Date
Key Partner
Countries Implemented In
Funds Raised to Date
Verified Funding


MiracleFeet works to unleash the potential of children affected by one of the greatest causes of physical disability in the world. Left untreated, clubfoot is a root cause of illiteracy, abuse, malnutrition, and poverty. Over one million children live with the condition, and 175,000 more are born with it each year. While we cannot eradicate the birth defect, we can prevent the lifelong disability it causes and change the trajectory of millions of lives. 95% of cases can be completel treated.



The Ponseti method, a non-surgical procedure, is well-suited to low-resource settings, making it feasible to address clubfoot on a global scale. By working closely with local healthcare providers in public hospitals, MiracleFeet leverages existing health infrastructure to increase access to treatment. MiracleFeet's innovative technology assists in keeping costs low and treatment quality high, and our program model promotes sustainability and integration into public health systems.

Target Beneficiaries

Over one million children live with untreated clubfoot, and 175,000 are born with clubfoot each year. Because they cannot walk properly, they are often marginalized and unable to attend school, with limited opportunities to participate in their communities. The families of these children are also affected. For this highly vulnerable and disadvantaged group of children and their families, treatment is a simple way to reduce stigma, abuse, illiteracy, neglect, and poverty.

Innovation Description

Clubfoot is easily and effectively treated with a simple, non-surgical treatment that involves a series of casts and brace wear. In 95% of cases, children treated with the Ponseti method experience full correction of the feet with few, if any, negative effects. For an average cost of only $250, treating a child with clubfoot unleashes an additional $120,000 in lifetime earnings, a Social Return of 480 times the initial investment.

MiracleFeet partners with local organizations, healthcare providers, and ministries of health to comprehensively build clinical capacity to treat clubfoot within existing health systems while changing awareness that clubfoot is treatable among medical and lay communities. We train healthcare workers in the Ponseti method and parent educators to support families and retain patients; ensure medical supplies are available; create early diagnosis and referral processes; expand clinical networks in countries to reduce travel time for families; and invest in clubfoot awareness campaigns.

In doing all of this, we are not just fixing feet. We are changing the way systems identify, treat, and track birth defects and disabilities, and our approaches can be applied to other childhood conditions requiring early medical attention. We play a critical role in advocating for and building the infrastructure required to address disabilities in low- and middle-income health systems.

Competitive Advantage

MiracleFeet offers an incredible return on investment: $250 changes a child’s life forever and generates an average of $120,000 of additional income in lifetime earnings--a social return of 480 times the original investment. Solving this problem is one of the most lucrative and effective investments in public health today.

A recent third-party impact evaluation of our work, conducted by Acumen, offers remarkable proof that our approach works and changes lives: 94% of 470 guardians surveyed reported their child can walk without difficulty or assistance—and 98% say their child’s quality of life has improved due to the treatment they received.

Measures of family satisfaction and treatment success were also remarkably high and uniform across countries studied. We received a Net Promoter Score of 83 from families in the evaluation—double Acumen's portfolio average of 42. (Apple, Amazon, and Netflix have scores of 66, 66, and 64 respectively)—evidence that MiracleFeet’s model and the Ponseti Method are highly effective and scalable.

Planned Goals and Milestones

Our goal is to create self-sustaining local clubfoot programs within 5-15 years that continue long after MiracleFeet support ends. The estimated cost to build a sustainable clubfoot program in every low- and middle-income country is $160M over 14 years—an average annual investment of $12M. MiracleFeet is seeking to raise an additional $15M over the next 3 years to expand the number of new children enrolled annually and the number of countries with programs.
Funding Goal15,000,000
Projected Cumulative Lives Impacted180,000

The Team Behind the Innovation



Apr 2019
New Country Implemented In
Brazil, Guinea, Guatemala, Gambia, The, Ecuador, Congo, Republic of the, Cambodia, Bolivia, Bangladesh, Senegal, Philippines, Nigeria, Nepal, Mali, Liberia, India, Uganda, Indonesia, Zimbabwe, Vietnam, Tanzania, Sri Lanka, Somalia, Paraguay, Nicaragua, Madagascar and Myanmar
Apr 2019
Lives Impacted
Jan 2019
Recognition ReceivedVERIFIED
2019 Innovator Cohort
Oct 2010